Association between TILs and other immunological biomarkers in the primary cohort (n = 95)
Biomarker | CD8 rich (n = 56) | CD8 poor (n = 39) | P value | CD4 rich (n = 76) | CD4 poor (n = 19) | P value |
---|---|---|---|---|---|---|
No. of patients | No. of patients | No. of patients | No. of patients | |||
Foxp3 | 0.002 | 0.010 | ||||
≥ 1% | 37 | 13 | 45 | 5 | ||
< 1% | 19 | 26 | 31 | 14 | ||
CD33 | 0.682 | 0.119 | ||||
≥ 1% | 38 | 28 | 50 | 16 | ||
< 1% | 18 | 11 | 26 | 3 | ||
PD-1 | 0.919 | 0.470 | ||||
≥ 1% | 25 | 17 | 35 | 7 | ||
< 1% | 31 | 22 | 41 | 12 | ||
PD-L1-TC | 0.555 | 0.581 | ||||
≥ 1% | 19 | 11 | 23 | 7 | ||
< 1% | 37 | 28 | 53 | 12 | ||
PD-L1-TC | 0.745 | 0.359 | ||||
≥ 10% | 10 | 8 | 13 | 5 | ||
< 10% | 46 | 31 | 63 | 14 | ||
PD-L1-IC | 0.026 | 0.316 | ||||
≥ 1% | 22 | 7 | 25 | 4 | ||
< 1% | 34 | 32 | 51 | 15 | ||
Tim-3 | 0.040 | 0.245 | ||||
≥ 1% | 26 | 10 | 31 | 5 | ||
< 1% | 30 | 29 | 45 | 14 | ||
LAG3 | 0.047 | 0.064 | ||||
≥ 1% | 13 | 3 | 16 | 0 | ||
< 1% | 43 | 36 | 60 | 19 | ||
OX40 | 0.535 | 0.107 | ||||
≥ 2% | 42 | 27 | 58 | 11 | ||
< 2% | 14 | 12 | 18 | 8 | ||
ICOS | 0.200 | 0.354 | ||||
≥ 6% | 29 | 15 | 37 | 7 | ||
< 6% | 27 | 24 | 39 | 12 | ||
IDO1-TC | 0.441 | 0.679 | ||||
≥ 1% | 26 | 15 | 32 | 9 | ||
< 1% | 30 | 24 | 44 | 10 | ||
IDO1-IC | 0.616 | 0.172 | ||||
≥ 6% | 17 | 10 | 24 | 3 | ||
< 6% | 39 | 29 | 52 | 16 |
TILs tumor infiltrating lymphocytes, TC tumor cell, IC immune cell
All entries in boldface are below 0.05